
biologics
-
-
Antitrust Featured Generic Drugs Greg Curfman Health Law Policy Intellectual Property Pharmaceuticals Public Health
3 Challenges to Patents on Therapeutic Monoclonal Antibodies
Read more: 3 Challenges to Patents on Therapeutic Monoclonal Antibodies -
Pharmaceutical Patents on Manufacturing Methods: Groundless or Well-Supported?
Read more: Pharmaceutical Patents on Manufacturing Methods: Groundless or Well-Supported? -
When “Pay-for-Delay” Becomes “Delay-Without-Pay”: Humira Antitrust Claims
Read more: When “Pay-for-Delay” Becomes “Delay-Without-Pay”: Humira Antitrust Claims -
Year in Review: Biosimilars
Read more: Year in Review: Biosimilars -
Aaron S. Kesselheim Ameet Sarpatwari Biotechnology Frazer Tessema Health Care Finance Health Care Reform Health Law Policy Medicare/Medicaid Pharmaceuticals PORTAL Round-Up
Monthly Round-Up of What to Read on Pharma Law and Policy
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy